For four days, the world’s leading experts will exchange ideas, share advances, discoveries, projects and update the status of the disease at the most important event in the world in leishmaniasis.
Due to the COVID-19 pandemic and uncertainty about the duration and effects of the disease, it was necessary to postpone Worldleish 7 for one year. Even with so many changes in the world dynamics, the organization of the event expects massive international participation and that there will be no difficulties for the Leishmaniac community from all over the world to be able to participate in person. The congress will be held between May 23 and 28, 2022 in the beautiful city of Cartagena de Indias (Colombia), declared a World Heritage Site by the United Nations Educational, Scientific and Cultural Organization (UNESCO).
Worldleish 7 Chair Dr. Iván Darío Vélez, recognizes that the preparations are going very well. “We have an international organizing committee formed by doctors Jorge Alvar, from the Medicines for Neglected Diseases (DNDi) initiative; Carlos Henrique Nery Costa (Brazil); Felix Tapia and Alexis Mendoza (Venezuela); Nancy Saravia, of the International Center for Medical Research and Investigations (CIDEIM); Gabriela Delgado (National University of Colombia) and researchers Carlos Muskus and Sara Robledo, from the Tropical Disease Learning and Control Program (PECET), from the University of Antioquia. We also have the support of Drs KP Chang, Luigi Gradoni and Jerome Depaqui”, he details. Still according to Dr. Velez, there is a preliminary scientific program, an official page where interested parties can review information about the event, social networks like Facebook and Twitter and a database with more than 1400 contacts related to the world of leishmaniasis. “Something fundamental is that we have the support of the Worldleish world committee for the activities of organizing the seventh version of the congress and our goal is to make a Worldleish 7 with quality and participation similar to WorldLeish 6, held in Toledo, in 2017. For this, we expect a significant participation of researchers and scholars of Leishmaniasis in Latin America”, he highlights.
Read the article complete here